Sign in

CIK 0001637715

  • Emerging growth company

OnKure Therapeutics, Inc.

Sign in to watch
Ticker
OKUR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472309515
Phone
+1 720-307-2892
Business address
6707 WINCHESTER CIRCLE, SUITE 400, BOULDER, CO, 80301
Former names
Reneo Pharmaceuticals, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 3 Insider Initial Statement of Ownership
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 3 Insider Initial Statement of Ownership
  10. 4 Open-market sale President and CEO sold 86 shares at $4.16 ($357)
  11. 4 Open-market sale Chief Financial Officer sold 301 shares at $4.16 ($1,251)
  12. 4 Grant or award Director acquired 3,911 shares (grant or award)
  13. 4 Grant or award Director acquired 5,258 shares (grant or award)
  14. 4 Open-market sale President and CEO sold 87 shares at $2.97 ($258)
  15. 4 Open-market sale Chief Financial Officer sold 302 shares at $2.97 ($896)
  16. 4 Grant or award Director acquired 4,125 shares (grant or award)
  17. 4 Grant or award Director acquired 5,545 shares (grant or award)
  18. 4 Open-market sale President and CEO sold 88 shares at $2.62 ($231)
  19. 4 Open-market sale Chief Financial Officer sold 303 shares at $2.62 ($795)
  20. 4 Grant or award Director acquired 4,694 shares (grant or award)

Page 2 of 9 · 171 filings